 |
|
Hepatitis B Vaccine Responsiveness in Connecticut Public Safety Personnel
Aaron J. Roome, PhD, MPH;
Stephen J. Walsh, ScD;
Matthew L. Cartter, MD;
James L. Hadler, MD, MPH
JAMA. 1993;270(24):2931-2934.
Abstract
| |
Objective.
—To determine the level and determinants of vaccine response in recently inoculated public safety personnel.
Design.
—Prevalence survey.
Participants.
—Public safety personnel who had completed vaccination 1 to 6 months prior to testing and had no serological evidence of previous exposure to hepatitis B virus.
Main Outcome Measure.
—An inadequate level of antibody to hepatitis B surface antigen was defined as less than 10 mlU/mL.
Results.
—All subjects in the study had been vaccinated using Recombivax HB, a recombinant hepatitis B vaccine. Of 528 individuals, 11.9% were found to have no or inadequate levels of antibody. The frequency of inadequate level of antibody increased significantly relative to age, from 2.8% among those younger than 30 years to 42.1% among those older than 60 years (P<.0001). Smoking (odds ratio [OR], 3.6; 95% confidence interval [CI], 2.0 to 6.4), extreme obesity (OR, 13.3; 95% CI, 3.8 to 49.1), and increasing time interval since completing the vaccine series (P<.01) were also associated with inadequate levels of antibody. These findings were confirmed by multivariate analysis using logistic regression.
Conclusions.
—Routine immunization of public safety personnel should include selective use of postvaccine testing. Postvaccination testing optimally should be performed in the 30- to 90-day interval after the last vaccine dose. New vaccination strategies are needed to improve response rates in persons with predictably poor response to hepatitis B vaccine.
(JAMA. 1993;270:2931-2934)
Author Affiliations
From the Epidemiology Section, Connecticut Department of Public Health and Addiction Services, Hartford (Drs Roome, Cartter, and Hadler), and Department of Community Medicine, University of Connecticut Health Center, Farmington (Dr Walsh).
Footnotes
Reprint requests to Epidemiology Section, Connecticut Department of Health and Addiction Services, 150 Washington St, Hartford, CT 06106 (Dr Hadler).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Blood Exposures and Hepatitis C Virus Infections Among Emergency Responders
Datta et al.
Arch Intern Med 2003;163:2605-2610.
ABSTRACT
| FULL TEXT
Post-exposure prophylaxis for blood borne viral infections in healthcare workers
Varghese et al.
Postgrad. Med. J. 2003;79:324-328.
ABSTRACT
| FULL TEXT
The Effect of Late Doses on the Achievement of Seroprotection and Antibody Titer Levels With Hepatitis B Immunization Among Adolescents
Middleman et al.
Pediatrics 2001;107:1065-1069.
ABSTRACT
| FULL TEXT
Smoking and Periodontal Disease
Kinane and Chestnutt
CROBM 2000;11:356-365.
ABSTRACT
| FULL TEXT
Decreasing occupational risk related to blood-borne viruses in cardiovascular surgery in Paris, France
Kuo et al.
Ann. Thorac. Surg. 1999;68:2267-2272.
ABSTRACT
| FULL TEXT
Hepatitis B Vaccine Administered to Children and Adolescents at Yearly Intervals
Halsey et al.
Pediatrics 1999;103:1243-1247.
ABSTRACT
| FULL TEXT
Update on Diagnosis, Management, and Prevention of Hepatitis B Virus Infection
Mahoney
Clin. Microbiol. Rev. 1999;12:351-366.
ABSTRACT
| FULL TEXT
Immunogenicity of a Recombinant Hepatitis B Vaccine in Adults
Bock et al.
Arch Intern Med 1996;156:2226-2231.
ABSTRACT
Evaluation of Needle Length and Hepatitis B Vaccine Response in Correctional Personnel in Massachusetts
Johnsen
J Correct Health Care 1995;2:39-45.
ABSTRACT
Immunogenicity of Hepatitis B Vaccines
Koff
JAMA 1994;272:201-201.
ABSTRACT
PREDICTORS OF POOR RESPONSE TO HEPATITIS B VACCINE
JWatch General 1994;1994:3-3.
FULL TEXT
Host Factors Related to Poor Immunogenicity of Hepatitis B Vaccine in Adults: Another Reason to Immunize Early
Margolis and Presson
JAMA 1993;270:2971-2972.
ABSTRACT
|
